Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules

RNA

Volumn 19, Issue 12, 2013, Pages 1825-1832

  Cox, Erica Machlin ^a   Sagan, Selena M ^a,b   Mortimer, Stefanie A W ^c   Doudna, Jennifer A ^c   Sarnow, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Argonaute 2; Dicer; Hepatitis C virus; MicroRNAs

Indexed keywords

ARGONAUTE 2 PROTEIN; DEOXYRIBONUCLEOTIDE; DICER; DNA; MESSENGER RNA; MICRORNA 122; OLIGONUCLEOTIDE; VIRUS RNA;

ARTICLE; BINDING SITE; CIRCADIAN RHYTHM; GENOME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER; MOLECULE; MUTATION; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; VIRUS GENOME;

ARGONAUTE 2; DICER; HEPATITIS C VIRUS; MICRORNAS;

ANIMALS; ARGONAUTE PROTEINS; BASE SEQUENCE; CIRCADIAN RHYTHM; FIBROBLASTS; GENE EXPRESSION; HELA CELLS; HEPACIVIRUS; HUMANS; INVERTED REPEAT SEQUENCES; MICE; MICRORNAS; RNA INTERFERENCE; RNA PRECURSORS; RNA STABILITY; RNA, VIRAL;

EID: 84888397691     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.040865.113     Document Type: Article

References (37)

1. Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger Y. 2011. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: A case-control study. J Viral Hepat 18: E399-E407.
2. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
4. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366.
5. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, et al. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1: 106-113.
6. Edwards PA, Muroya H, Gould RG. 1972. In vivo demonstration of the circadian rhythm of cholesterol biosynthesis in the liver and intestine of the rat. J Lipid Res 13: 396-401.
7. Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, Ruskeepaa AL, Oresic M, Esau CC, Zdobnov EM, et al. 2009. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 23: 1313-1326.
8. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. 2004. The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240.
9. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. 2005. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123: 631-640.
10. Han JJ, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. 2004. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18: 3016-3027.
11. Helwak A, Kudla G, Dudnakova T, Tollervey D. 2013. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153: 654-665.
12. Hoofnagle JH. 2002. Course and outcome of hepatitis C. Hepatology 36: S21-S29.
13. Hu ZB, Chen JP, Tian T, Zhou XY, Gu HY, Xu L, Zeng Y, Miao RF, Jin GF, Ma HX, et al. 2008. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
14. Jangra RK, Yi M, Lemon SM. 2010. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84: 6615-6625.
15. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al. 2013. Treatment of HCV infection by targeting microRNA. N Engl J Med 368: 1685-1694.
16. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309: 1577-1581.
17. Jopling CL, Schuetz S, Sarnow P. 2008. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4: 77-85.
18. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. 2002. MicroRNA maturation: Stepwise processing and subcellular localization. EMBO J 21: 4663-4670.
19. Lee Y, Ahn C, Han JJ, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
20. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115: 787-798.
21. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
22. Liu G, Min H, Yue S, Chen CZ. 2008. Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1 and mir-181c in early T cell development. PLoS One 3: e3592.
23. Machlin ES, Sarnow P, Sagan SM. 2011. Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci 108: 3193-3198.
24. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA. 2008. In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci 105: 512-517.
25. Maniataki E, Mourelatos Z. 2005. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev 19: 2979-2990.
26. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15: 185-197.
27. Moradpour D, Penin F, Rice CM. 2007. Replication of hepatitis C virus. Nat Rev Microbiol 5: 453-463.
28. Norman KL, Sarnow P. 2010. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J Virol 84: 666-670.
29. Park JE, Heo I, Tian Y, Simanshu DK, Chang H, Jee D, Patel DJ, Kim VN. 2011. Dicer recognizes the 5′ end of RNA for efficient and accurate processing. Nature 475: 201-205.
30. Qi P, Dou TH, Geng L, Zhou FG, Gu X, Wang H, Gao CF. 2010. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 71: 621-626.
31. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM. 2012a. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci 109: 941-946.
32. Shimakami T, Yamane D, Welsch C, Hensley L, Jangra RK, Lemon SM. 2012b. Base pairing between hepatitis C virus RNA and microRNA 122 3′ of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol 86: 7372-7383.
33. Solda G, Robusto M, Primignani P, Castorina P, Benzoni E, Cesarani A, Ambrosetti U, Asselta R, Duga S. 2012. A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing. Hum Mol Genet 21: 577-585.
34. Tan GS, Garchow BG, Liu XH, Yeung J, Morris JP, Cuellar TL, McManus MT, Kiriakidou M. 2009. Expanded RNA-binding activities of mammalian Argonaute 2. Nucleic Acids Res 37: 7533-7545.
35. Yi R, Qin Y, Macara IG, Cullen BR. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016.
36. Yoda M, Kawamata T, Paroo Z, Ye XC, Iwasaki S, Liu QH, Tomari Y. 2010. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17: 17-23.
37. Zhang C, Huys A, Thibault PA, Wilson JA. 2012. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance. Virology 433: 479-488.